Benzo[e]isoindole-1,3-diones as Potential Inhibitors of Glycogen Synthase Kinase-3 (GSK-3). Synthesis, Kinase Inhibitory Activity, Zebrafish Phenotype, and Modeling of Binding Mode

被引：46

作者：

Zou, Haixia ^{[1
,2
,3
]}

Zhou, Liyan ^{[1
]}

Li, Yuanzhen ^{[1
]}

Cui, Yi ^{[1
]}

Zhong, Hanbing ^{[1
]}

Pan, Zhengying ^{[1
]}

Yang, Zhen ^{[1
,2
,3
]}

Quan, Junmin ^{[1
]}

机构：

[1] Peking Univ, Shenzhen Grad Sch, Lab Chem Genom, Shenzhen, Peoples R China

[2] Peking Univ, Coll Chem, BNLMS, Beijing 100871, Peoples R China

[3] Peking Univ, Minist Educ, Key Lab Bioorgan Chem & Mol Engn, Beijing 100871, Peoples R China

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2010年 / 53卷 / 03期

基金：

美国国家科学基金会;

关键词：

SELECTIVE INHIBITORS; GSK-3; TARGET; ROLES;

D O I：

10.1021/jm9013373

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Benzo[e]isoindole-1,3-dione derivatives were synthesized, and the effects on GSK-3 beta activity and zebrafish embryo growth were evaluated. A series of derivatives show obvious inhibitory activity against GSK-3 beta. The most potent inhibitor, 7,8-dimethoxy-5-methylbenzo[e]isoindole-1,3-dione (8a), shows nanomolar IC50 and obvious phenotype on zebrafish embryo growth associated with the inhibition of GSK-3 beta at low micromolar concentration. The interaction mode between 8a and GSK-3 beta was characterized by computational modeling.

引用

页码：994 / 1003

页数：10

共 32 条

[1] Glycogen synthase kinase-3 (GSK-3) inhibitors reach the clinic
Medina, Miguel
Castro, Ana
CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2008, 11 (04) : 533 - 543
[2] Glycogen Synthase Kinase-3 (GSK-3) Inhibitors for the Treatment of Alzheimer's Disease
Medina, Miguel
Avila, Jesus
CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (25) : 2790 - 2798
[3] Design, synthesis and evaluation of 7-azaindazolyl-indolylmaleimides as glycogen synthase kinase-3β (GSK-3β) inhibitors
Ye, Qing
Shen, Yanhong
Zhou, Yubo
Lv, Dan
Gao, Jianrong
Li, Jia
Hu, Yongzhou
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 68 : 361 - 371
[4] Synthesis and biological evaluation of novel 4-azaindolyl-indolyl-maleimides as glycogen synthase kinase-3β (GSK-3β) inhibitors
Ye, Qing
Xu, Guiqing
Lv, Dan
Cheng, Zhe
Li, Jia
Hu, Yongzhou
BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (13) : 4302 - 4312
[5] Identification of CNS compatible small molecules as glycogen synthase kinase-3β (GSK-3β) inhibitors through structure-based virtual screening
Sukanya, Sukanya
Choudhary, Bhanwar Singh
Mehta, Pakhuri
Filipek, Slawomir
Malik, Ruchi
MEDICINAL CHEMISTRY RESEARCH, 2022, 31 (09) : 1545 - 1557
[6] 2,5-Diaminopyrimidines and 3,5-disubstituted azapurines as inhibitors of glycogen synthase kinase-3 (GSK-3)
Lum, Christopher
Kahl, Jeff
Kessler, Linda
Kucharski, Jeff
Lundstrom, Jan
Miller, Stephen
Nakanishi, Hiroshi
Pei, Yazhong
Pryor, Kent
Roberts, Edward
Sebo, Lubomir
Sullivan, Robert
Urban, Jan
Wang, Zhijun
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (12) : 3578 - 3581
[7] Design, synthesis and biological evaluation of benzothiazepinones (BTZs) as novel non-ATP competitive inhibitors of glycogen synthase kinase-3β (GSK-3β)
Zhang, Peng
Hu, Hai-Rong
Bian, Shi-Hui
Huang, Zhao-Hui
Chu, Yong
Ye, De-Yong
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 61 : 95 - 103
[8] 3D-QSAR STUDY OF MALEIMIDE ANALOGUES AS GLYCOGEN SYNTHASE KINASE-3 (GSK-3) INHIBITORS USING CoMSIA APPROACH
Crisan, Luminita
Avram, Sorin
Bora, Alina
Kurunczi, Ludovic
Pacureanu, Liliana
REVUE ROUMAINE DE CHIMIE, 2015, 60 (2-3) : 183 - 188
[9] Structure-based design of benzo[e]isoindole-1,3-dione derivatives as selective GSK-3β inhibitors to activate Wnt/β-catenin pathway
Yue, Hong
Lu, Feng
Shen, Chen
Quan, Jun-Min
BIOORGANIC CHEMISTRY, 2015, 61 : 21 - 27
[10] Therapeutic Potential Effect of Glycogen Synthase Kinase 3 Beta (GSK-3β) Inhibitors in Parkinson Disease: Exploring an Overlooked Avenue
Turkistani, Areej
Al-kuraishy, Hayder M.
Al-Gareeb, Ali I.
Albuhadily, Ali K.
Alexiou, Athanasios
Papadakis, Marios
Elfiky, Mohamed M.
Saad, Hebatallah M.
Batiha, Gaber El-Saber
MOLECULAR NEUROBIOLOGY, 2024, 61 (09) : 7092 - 7108

← 1 2 3 4 →